Global ePRO, E-Patient Diaries and eCOA Industry (2020 to 2027) - Market Trajectory & Analytics - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "ePRO, E-Patient Diaries and eCOA - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for ePRO, E-Patient Diaries and eCOA estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 14.7% over the period 2020-2027.

eCOA, one of the segments analyzed in the report, is projected to record 14.1% CAGR and reach US$2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the E-Patient Diaries segment is readjusted to a revised 15.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $366.9 Million, While China is Forecast to Grow at 14.2% CAGR

The ePRO, E-Patient Diaries and eCOA market in the U.S. is estimated at US$366.9 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$566.3 Million by the year 2027 trailing a CAGR of 14.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.1% and 12.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.8% CAGR.

Select Competitors (Total 46 Featured):

• ArisGlobal LLC
• Bracket Global LLC
• CRF Health
• ERT Clinical
• HealthDiary Inc.
• ICON PLC
• Kayentis SAS
• Medidata Solutions, Inc.
• OmniComm Systems, Inc.
• Parexel International Corporation

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/bnor2f